Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-66,512
Closed -$98K – 11756
2022
Q2
$98K Buy
66,512
+65,012
+4,334% +$47.8K ﹤0.01% 5450
2022
Q1
$2K Hold
1,500
– – ﹤0.01% 9807
2021
Q4
$4K Sell
1,500
-38,902
-96% -$153K ﹤0.01% 9621
2021
Q3
$207K Buy
40,402
+38,902
+2,593% +$236K ﹤0.01% 5288
2021
Q2
$12K Sell
1,500
-118,099
-99% -$996K ﹤0.01% 7933
2021
Q1
$1.04M Buy
119,599
+117,639
+6,002% +$1.22M ﹤0.01% 4208
2020
Q4
$21K Sell
1,960
-500
-20% -$6.17K ﹤0.01% 6929
2020
Q3
$29K Buy
2,460
+960
+64% +$12.9K ﹤0.01% 6032
2020
Q2
$24K Sell
1,500
-2,898
-66% -$50.6K ﹤0.01% 6447
2020
Q1
$68K Sell
4,398
-21,630
-83% -$465K ﹤0.01% 5588
2019
Q4
$640K Sell
26,028
-146,676
-85% -$2.18M ﹤0.01% 4616
2019
Q3
$1.78M Buy
172,704
+79,977
+86% +$1.01M ﹤0.01% 3411
2019
Q2
$1.16M Buy
92,727
+39,978
+76% +$514K ﹤0.01% 3631
2019
Q1
$654K Sell
52,749
-218,091
-81% -$2.44M ﹤0.01% 3874
2018
Q4
$1.67M Buy
270,840
+176,853
+188% +$1.35M ﹤0.01% 3215
2018
Q3
$997K Buy
93,987
+9,484
+11% +$108K ﹤0.01% 3852
2018
Q2
$1.14M Sell
84,503
-30,237
-26% -$471K ﹤0.01% 3667
2018
Q1
$2.04M Buy
114,740
+102,620
+847% +$1.73M ﹤0.01% 3124
2017
Q4
$152K Sell
12,120
-23,790
-66% -$346K ﹤0.01% 5100
2017
Q3
$684K Buy
35,910
+22,833
+175% +$348K ﹤0.01% 3987
2017
Q2
$197K Buy
13,077
+10,525
+412% +$159K ﹤0.01% 4752
2017
Q1
$44K Sell
2,552
-8,125
-76% -$108K ﹤0.01% 5609
2016
Q4
$129K Buy
10,677
+6,912
+184% +$72.1K ﹤0.01% 5115
2016
Q3
$37K Buy
3,765
+636
+20% +$5.8K ﹤0.01% 5759
2016
Q2
$32K Buy
3,129
+179
+6% +$2K ﹤0.01% 5889
2016
Q1
$36K Sell
2,950
-37,441
-93% -$379K ﹤0.01% 5754
2015
Q4
$647K Buy
40,391
+37,441
+1,269% +$555K ﹤0.01% 3749
2015
Q3
$38K Sell
2,950
-679
-19% -$13.7K ﹤0.01% 6074
2015
Q2
$87K Buy
3,629
+479
+15% +$9.22K ﹤0.01% 5522
2015
Q1
$59K Buy
3,150
+488
+18% +$10.1K ﹤0.01% 5899
2014
Q4
$50K Sell
2,662
-1,677
-39% -$39.2K ﹤0.01% 6487
2014
Q3
$118K Buy
4,339
+1,130
+35% +$35.1K ﹤0.01% 5792
2014
Q2
$100K Buy
3,209
+114
+4% +$2.68K ﹤0.01% 5948
2014
Q1
$70K Sell
3,095
-304
-9% -$9.22K ﹤0.01% 6413
2013
Q4
$71K Sell
3,399
-5,330
-61% -$155K ﹤0.01% 6497
2013
Q3
$350K Buy
+8,729
New +$296K ﹤0.01% 4541

Other funds holding EPZM

UBS Group's EPZM Position: Q3 2022 in Review

UBS Group sold out of Epizyme (EPZM) in Q3 2022, closing a stake of 66,512 shares — an estimated $98K sold.

UBS Group first reported a position in EPZM in Q3 2013 and held it in 36 quarters. The position peaked at $2.04M in Q1 2018. 0 funds tracked by Wall St. Rank hold EPZM as of Q3 2022.

  • UBS Group reported no remaining Epizyme position as of Q3 2022 after selling out during the quarter.
  • UBS Group sold 66,512 Epizyme shares in Q3 2022, an estimated $98K.
  • UBS Group first reported a position in Epizyme in Q3 2013 and held it in 36 quarters.
  • UBS Group's Epizyme position peaked at $2.04M in Q1 2018.
  • 0 funds tracked by Wall St. Rank held Epizyme as of Q3 2022.

Based on UBS Group's 13F filing for Q3 2022, filed 10 Nov 2022.